Do patients with juvenile idiopathic arthritis in clinical remission have evidence of persistent inflammation on 3T magnetic resonance imaging?

Arthritis Care and Research

Volumn 64, Issue 12, 2012, Pages 1846-1854

  Brown, Amanda ^a   Hirsch, Raphael ^b   Laor, Tal ^c   Hannon, Michael J ^d   Levesque, Marc C ^d   Starz, Terence ^d   Francis, Kimberly ^b   Kwoh, C Kent ^d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GADOBENATE DIMEGLUMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW DISEASE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HAND; HOSPITALIZED CHILD; HUMAN; JOINT LIMITATION; JOINT SWELLING; JUVENILE RHEUMATOID ARTHRITIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; QUALITY OF LIFE; REMISSION; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SELF REPORT; SYNOVITIS; TENOSYNOVITIS; THREE DIMENSIONAL IMAGING; WRIST;

ADOLESCENT; ADULT; AGED; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CHILD; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HAND JOINTS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; SINGLE-BLIND METHOD; SYNOVITIS; WRIST JOINT; YOUNG ADULT;

EID: 84870535672     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21774     Document Type: Article

References (45)

1. Wallace CA,. Current management of juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2006; 20: 279-300.
2. Bartoli M, Taro M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, et al. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis 2008; 67: 370-4.
3. Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 2009; 68: 635-41.
4. Woo P,. Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders. Curr Opin Rheumatol 2009; 21: 552-7.
5. Breedveld FC, Emery P, Keystone E, Patel K, Furst DE, Kalden JR, et al. Infliximab in active early rheumatoid arthritis. Ann Rheum Dis 2004; 63: 149-55.
6. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46: 347-56.
7. Magnani A, Pistorio A, Magni-Manzoni S, Falcone A, Lombardini G, Bandeira M, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol 2009; 36: 628-34.
8. Wallace CA, Ravelli A, Huang B, Giannini EH,. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis. J Rheumatol 2006; 33: 789-95.
9. Wallace CA, Ruperto N, Giannini E,. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290-4.
10. Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E,. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10-year followup. J Rheumatol 2003; 30: 579-84.
11. Fernandes TA, Corrente JE, Magalhaes CS,. Remission status follow-up in children with juvenile idiopathic arthritis. J Pediatr (Rio J) 2007; 83: 141-8.
12. Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2392-401.
13. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M,. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002; 29: 1989-99.
14. Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH,. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 3554-62.
15. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
16. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54: 3761-73.
17. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2958-67.
18. Saleem B, Brown AK, Keen H, Nizam S, Freeston J, Wakefield R, et al. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis 2011; 70: 792-8.
19. Wakefield RJ, Freeston JE, Hensor EM, Bryer D, Quinn MA, Emery P,. Delay in imaging versus clinical response: a rationale for prolonged treatment with anti-tumor necrosis factor medication in early rheumatoid arthritis. Arthritis Rheum 2007; 57: 1564-7.
20. Prieur AM, Chedeville G,. Prognostic factors in juvenile idiopathic arthritis. Curr Rheumatol Rep 2001; 3: 371-8.
21. Harris E Jr, Firestein G,. Clinical features of rheumatoid arthritis. In:, Firestein G, editor. Kelley's textbook of rheumatology. 8th ed. Philadelphia: W. B. Saunders Company; 2008. p. 1087-118.
22. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2.
23. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
24. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011; 63: 573-86.
25. Bruce B, Fries JF,. The Stanford Health Assessment Questionnaire: dimensions and practical applications. Health Qual Life Outcomes 2003; 1: 20.
26. Singh G, Athreya BH, Fries JF, Goldsmith DP,. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994; 37: 1761-9.
27. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796-806.
28. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
29. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244-57.
30. Ringold S, Chon Y, Singer NG,. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: a secondary analysis of clinical trial data from children with polyarticular-course juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 3776-83.
31. Malattia C, Damasio MB, Pistorio A, Ioseliani M, Vilca I, Valle M, et al. Development and preliminary validation of a paediatric-targeted MRI scoring system for the assessment of disease activity and damage in juvenile idiopathic arthritis. Ann Rheum Dis 2011; 70: 440-6.
32. Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies: core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003; 30: 1385-6.
33. Magni-Manzoni S, Scire CA, Ravelli A, Klersy C, Rossi S, Muratore V,. High frequency of subclinical ultrasound-detected synovitis in juvenile idiopathic arthritis patients with clinically-defined inactive disease [abstract]. Arthritis Rheum 2010; 62 Suppl: S933.
34. Pincus T,. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis 2008; 66: 216-23.
35. Mulherin D, Fitzgerald O, Bresnihan B,. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996; 35: 1263-8.
36. Haslam KE, McCann LJ, Wyatt S, Wakefield RJ,. The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study. Rheumatology (Oxford) 2010; 49: 123-7.
37. Magni-Manzoni S, Epis O, Ravelli A, Klersy C, Veisconti C, Lanni S, et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 1497-504.
38. Cannizzaro E, Schroeder S, Muller LM, Kellenberger CJ, Saurenmann RK,. Temporomandibular joint involvement in children with juvenile idiopathic arthritis. J Rheumatol 2011; 38: 510-5.
39. Weiss PF, Arabshahi B, Johnson A, Bilaniuk LT, Zarnow D, Cahill AM, et al. High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound. Arthritis Rheum 2008; 58: 1189-96.
40. Gardner-Medwin JM, Killeen OG, Ryder CA, Bradshaw K, Johnson K,. Magnetic resonance imaging identifies features in clinically unaffected knees predicting extension of arthritis in children with monoarthritis. J Rheumatol 2006; 33: 2337-43.
41. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 2011; 63: 465-82.
42. Donnithorne KJ, Cron RQ, Beukelman T,. Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: enthesitis-related arthritis predicts persistent active disease. J Rheumatol 2011; 38: 2675-81.
43. Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, et al. Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA 2011; 306: 2340-7.
44. Muller LS, Avenarius D, Damasio B, Eldevik OP, Malattia C, Lambot-Juhan K, et al. The paediatric wrist revisited: redefining MR findings in healthy children. Ann Rheum Dis 2011; 70: 605-10.
45. Shenoi S, Wallace CA,. Remission in juvenile idiopathic arthritis: current facts. Curr Rheumatol Rep 2010; 12: 80-6.